As of 2024-12-14, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (383.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.07 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -1226.2%.
The range of the Relative Valuation is (238.79) - (404.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 24.1x | 17.3x |
| Forward P/E multiples | 11.1x - 18.9x | 18.5x |
| Fair Price | (238.79) - (404.27) | (383.69) |
| Upside | -800.9% - -1286.6% | -1226.2% |
| Date | P/E |
| 2024-11-29 | -1.19 |
| 2024-11-27 | -1.07 |
| 2024-11-26 | -1.00 |
| 2024-11-25 | -0.95 |
| 2024-11-22 | -0.93 |
| 2024-11-21 | -0.92 |
| 2024-11-20 | -0.85 |
| 2024-11-19 | -0.86 |
| 2024-11-18 | -0.94 |
| 2024-11-15 | -0.89 |
| 2024-11-14 | -0.91 |
| 2024-11-13 | -0.91 |
| 2024-11-12 | -0.83 |
| 2024-11-11 | -0.65 |
| 2024-11-08 | -0.48 |
| 2024-11-07 | -0.46 |
| 2024-11-06 | -0.44 |
| 2024-11-05 | -0.46 |
| 2024-11-04 | -0.44 |
| 2024-11-01 | -0.45 |
| 2024-10-31 | -0.46 |
| 2024-10-30 | -0.46 |
| 2024-10-29 | -0.44 |
| 2024-10-28 | -0.41 |
| 2024-10-25 | -0.39 |
| 2024-10-24 | -0.42 |
| 2024-10-23 | -0.34 |
| 2024-10-22 | -0.34 |
| 2024-10-21 | -0.34 |
| 2024-10-18 | -0.34 |
| 2024-10-17 | -0.34 |
| 2024-10-16 | -0.34 |
| 2024-10-15 | -0.34 |
| 2024-10-14 | -0.34 |
| 2024-10-11 | -0.36 |
| 2024-10-10 | -0.32 |
| 2024-10-09 | -0.36 |
| 2024-10-08 | -0.34 |
| 2024-10-07 | -0.35 |
| 2024-10-04 | -0.38 |
| 2024-10-03 | -0.38 |
| 2024-10-02 | -0.40 |
| 2024-10-01 | -0.40 |
| 2024-09-30 | -0.40 |
| 2024-09-27 | -0.38 |
| 2024-09-26 | -0.37 |
| 2024-09-25 | -0.38 |
| 2024-09-24 | -0.38 |
| 2024-09-23 | -0.38 |
| 2024-09-20 | -0.43 |